Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Reporter Virgin Islands.
Press releases published on August 27, 2025
Voting Rights and Shares Capital of the Company
GlobeNewswire
·
August 27, 2025
In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Market: Euronext Paris / Nasdaq …
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
GlobeNewswire
·
August 27, 2025
Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers PARIS, 27 août 2025 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Paris / Nasdaq Euronext Compartiment : B Code ISIN : …
JointCommerce Expands Programmatic Capabilities to Help Retailers and Brands in Highly Regulated Verticals Reach Verified Consumers and Link Ads to Sales
GlobeNewswire
·
August 27, 2025
JointCommerce Logo LOS ANGELES, Aug. 27, 2025 (GLOBE NEWSWIRE) -- JointCommerce, a programmatic advertising technology and consumer data marketplace platform, today announced expanded capabilities that enable retailers and brands in highly regulated …
BioVersys Receives EMA Orphan Designation for the Combination of Alpibectir and Ethionamide for the Treatment of Tuberculosis
GlobeNewswire
·
August 27, 2025
Ad hoc announcement pursuant to Art. 53 LR BASEL, Switzerland, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Orphan designation is granted to drug candidates addressing life-threatening or chronically debilitating diseases affecting fewer than 5 in 10’000 EU residents …
Junshi Biosciences Announces 2025 Interim Financial Results and Provides Corporate Updates
GlobeNewswire
·
August 27, 2025
SHANGHAI, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel …